GlaxoSmithKline (Comparative Multiple Analysis)
Improve your investment analysis with by seeing the GlaxoSmithKline's Discounted Cash Flow analysis, GlaxoSmithKline's Warren Buffet analysis, and GlaxoSmithKline's Weighted Average Cost of Capital (WACC) Analysis.
Notes on the Comparative Multiple Analysis of GlaxoSmithKline
WikiWealth compares GlaxoSmithKline's revenue, EBITDA, and EBIT multiples to their peers in order to determine the appropriate fair valuation. Click in the top right corner to experiment with GlaxoSmithKline's comparative analysis.
Notes from the analysis:
1. WikiWealth uses quantitative measures to determine the multiple range for GlaxoSmithKline.
Helpful Information for GlaxoSmithKline's Analysis
How does this work? The Comparative Investment Analysis determines the value of GlaxoSmithKline by comparing GlaxoSmithKline financial ratios, prices, growth rates, margins, etc. to those of relevant peer groups.
Value Investing Importance? This method is widely used by investment professionals to determine the correct price of investments, especially initial public offerings (IPOs). It is one element of WikiWealth's three Wall Street approaches used to determine the correct fair value of GlaxoSmithKline.
Also, see the GlaxoSmithKline's buffett intrinsic valuation analysis for WikiWealth's attempt to replicate the investing formula's used by Warren Buffett and GlaxoSmithKline's valuation conclusion for a quick summary.